Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies.

Yannick Tholance Christian Peter MoritzCarole RosierKarine FerraudFrançois LassablièreEvelyne Reynaud-FederspielMarcondes C FrançaAlberto R M MartinezJean-Philippe CamdessanchéJean-Christophe Antoinenull null

Published in: Journal of neurology, neurosurgery, and psychiatry (2019)

Anti-FGFR3 antibodies occur in a subgroup of SN probably predominantly affecting the DRG. Differences between Europeans and Brazilians could suggest involvement of genetic or environmental factors.

Keyphrases

systemic lupus erythematosus
genome wide
clinical trial
gene expression
dna methylation
african american
phase iii
open label
double blind